- Xenon Pharmaceuticals Inc Corporate Update TranscriptNov 27, 2023
- Q3 2023 Xenon Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2023€29.2 (-2.67%)Earnings
- Xenon Pharmaceuticals Inc XEN1101 and the Major Depressive Disorder (MDD) Landscape: A Discussion with KOLs TranscriptSep 19, 2023
- Q2 2023 Xenon Pharmaceuticals Inc Earnings Call TranscriptAug 09, 2023€32.4Earnings
- Xenon Pharmaceuticals Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Xenon Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Xenon Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 01, 2023
- Xenon Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 16, 2023
- Xenon Pharmaceuticals Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Xenon Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2023€39 (+3.17%)Earnings
- Xenon Pharmaceuticals Inc at Bloom Burton & Co Healthcare Investor Conference TranscriptApr 25, 2023
- Xenon Pharmaceuticals Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2023
- Q4 2022 Xenon Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2023€37.2 (+3.33%)Earnings
- Xenon Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Xenon Pharmaceuticals Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Q3 2022 Xenon Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2022€34.2 (-2.84%)Earnings
- Q2 2022 Xenon Pharmaceuticals Inc Earnings Call TranscriptAug 09, 2022€38 (-1.04%)Earnings
- Xenon Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 01, 2022
- Q1 2022 Xenon Pharmaceuticals Inc Earnings Call TranscriptMay 10, 2022€24 (-2.44%)Earnings
- Xenon Pharmaceuticals Inc at Bloom Burton & Co. Healthcare Investor Conference TranscriptMay 03, 2022
- Xenon Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) TranscriptApr 11, 2022
- Xenon Pharmaceuticals Inc at Stifel CNS Days (Virtual) TranscriptMar 29, 2022
- Q4 2021 Xenon Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2022€27.8 (+2.21%)Earnings
- Xenon Pharmaceuticals Inc X-TOLE Results Update AES 2021 Call TranscriptDec 03, 2021
- Q3 2021 Xenon Pharmaceuticals Inc Earnings Call TranscriptNov 10, 2021€29 (-2.03%)Earnings
- Xenon Pharmaceuticals Inc Positive Topline Results from Phase 2b 'X-TOLE' Clinical Trial of XEN1101 Call TranscriptOct 04, 2021
- Q2 2021 Xenon Pharmaceuticals Inc Earnings Call TranscriptAug 11, 2021€14.1 (-1.40%)Earnings
- Xenon Pharmaceuticals Inc at William Blair Biotech Focus Conference (Virtual) TranscriptJul 15, 2021
- Xenon Pharmaceuticals Inc Discussion of XEN1101 and the Focal Epilepsy Landscape TranscriptJul 12, 2021
- Q1 2021 Xenon Pharmaceuticals Inc Earnings Call TranscriptMay 11, 2021€14.7 (-2.00%)Earnings
- Full Year 2020 Xenon Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2021€15.3 (+5.52%)Earnings
- Q3 2020 Xenon Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020€9.8 (+5.38%)Earnings
- Q2 2020 Xenon Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2020€9.3 (-2.62%)Earnings
- Xenon Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 01, 2020
- Q1 2020 Xenon Pharmaceuticals Inc Earnings Call TranscriptMay 21, 2020€12.6 (-1.56%)Earnings
- Q4 2019 Xenon Pharmaceuticals Inc Earnings Call TranscriptMar 09, 2020€11.5 (-12.88%)Earnings
- Xenon Pharmaceuticals Inc. - Special Call TranscriptDec 02, 2019
- Q3 2019 Xenon Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2019€8.05 (+3.87%)Earnings
- Q2 2019 Xenon Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2019€7.97 (+1.22%)Earnings
- Q1 2019 Xenon Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2019€8.2 (-4.82%)Earnings
- Full Year 2018 Xenon Pharmaceuticals Inc Earnings Call TranscriptMar 06, 2019€7.52 (-0.92%)Earnings
Xenon Pharmaceuticals Inc at Bloom Burton & Co Healthcare Investor Conference Transcript
We have Xenon Pharmaceuticals. And we have Ian Mortimer, President and CEO. Take it away, Ian.
Thanks, Andrew. Good morning, everyone, and thanks for joining. It's been -- it's great to be back at the Bloom Burton conference. Lot of progress at Xenon over the last years, so nice opportunity to give you an update on.
I will be making some forward-looking statements, so I do refer you to our full risk factor disclosure filed with the SEC and also filed on SEDAR.
For those that are newer to the Xenon's story, we're a neurology company. We've built really strong capabilities of drugging ion channels in the CNS. We've been doing this for about 15 years or so.
Over the last number of years, we've built really strong capabilities in epilepsy drug development from preclinical modeling and pharmacology, all the way through clinical development. And our goal strategically is to forward integrate into a commercial organization, and we plan to launch our lead program
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)